Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Return on Equity (2016 - 2020)

Historic Return on Equity for Glucotrack (GCTK) over the last 6 years, with Q3 2020 value amounting to 0.41%.

  • Glucotrack's Return on Equity fell 39800.0% to 0.41% in Q3 2020 from the same period last year, while for Sep 2020 it was 0.41%, marking a year-over-year decrease of 39800.0%. This contributed to the annual value of 1.64% for FY2019, which is 23100.0% down from last year.
  • Glucotrack's Return on Equity amounted to 0.41% in Q3 2020, which was down 39800.0% from 0.38% recorded in Q2 2020.
  • Glucotrack's 5-year Return on Equity high stood at 4.39% for Q3 2019, and its period low was 4.88% during Q4 2019.
  • Over the past 5 years, Glucotrack's median Return on Equity value was 0.29% (recorded in 2017), while the average stood at 0.12%.
  • Over the last 5 years, Glucotrack's Return on Equity had its largest YoY gain of 54100bps in 2019, and its largest YoY loss of -51700bps in 2019.
  • Over the past 5 years, Glucotrack's Return on Equity (Quarter) stood at 0.54% in 2016, then crashed by -285bps to 1.0% in 2017, then surged by 129bps to 0.29% in 2018, then crashed by -1795bps to 4.88% in 2019, then surged by 108bps to 0.41% in 2020.
  • Its last three reported values are 0.41% in Q3 2020, 0.38% for Q2 2020, and 0.79% during Q1 2020.